190 related articles for article (PubMed ID: 31210942)
1. Hepatitis C virus therapy in advanced liver disease: Outcomes and challenges.
Ekpanyapong S; Reddy KR
United European Gastroenterol J; 2019 Jun; 7(5):642-650. PubMed ID: 31210942
[TBL] [Abstract][Full Text] [Related]
2. DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort.
Verna EC; Morelli G; Terrault NA; Lok AS; Lim JK; Di Bisceglie AM; Zeuzem S; Landis CS; Kwo P; Hassan M; Manns MP; Vainorius M; Akushevich L; Nelson DR; Fried MW; Reddy KR
J Hepatol; 2020 Sep; 73(3):540-548. PubMed ID: 32243960
[TBL] [Abstract][Full Text] [Related]
3. Treatment strategies for patients with decompensated liver cirrhosis due to hepatitis C virus infection eligible for liver transplantation: real-life data from five German transplant centers.
Sandmann L; Dörge P; Wranke A; Vermehren J; Welzel TM; Berg CP; Grottenthaler JM; Weiss KH; Langel J; Sterneck M; von Wulffen M; Manns MP; Wedemeyer H; Hardtke S; von Hahn T
Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):1049-1056. PubMed ID: 30807443
[TBL] [Abstract][Full Text] [Related]
4. Direct antiviral therapy for hepatitis C cirrhotic patients in liver transplantation settings: a systematic review.
Li J; Wu V; Pan CQ
Hepatol Int; 2022 Oct; 16(5):1020-1031. PubMed ID: 36085539
[TBL] [Abstract][Full Text] [Related]
5. Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.
El-Sherif O; Jiang ZG; Tapper EB; Huang KC; Zhong A; Osinusi A; Charlton M; Manns M; Afdhal NH; Mukamal K; McHutchison J; Brainard DM; Terrault N; Curry MP
Gastroenterology; 2018 Jun; 154(8):2111-2121.e8. PubMed ID: 29535028
[TBL] [Abstract][Full Text] [Related]
6. Considerations When Treating Hepatitis C in a Cirrhotic Transplant Candidate.
Daniel KE; Said A
Curr Gastroenterol Rep; 2018 Apr; 20(5):20. PubMed ID: 29623506
[TBL] [Abstract][Full Text] [Related]
7. Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.
Flemming JA; Kim WR; Brosgart CL; Terrault NA
Hepatology; 2017 Mar; 65(3):804-812. PubMed ID: 28012259
[TBL] [Abstract][Full Text] [Related]
8. Treat chronic hepatitis C virus infection in decompensated cirrhosis - pre- or post-liver transplantation? the ironic conundrum in the era of effective and well-tolerated therapy.
Bunchorntavakul C; Reddy KR
J Viral Hepat; 2016 Jun; 23(6):408-18. PubMed ID: 27018088
[TBL] [Abstract][Full Text] [Related]
9. Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis.
Maan R; van Tilborg M; Deterding K; Ramji A; van der Meer AJ; Wong F; Fung S; Sherman M; Manns MP; Cornberg M; Hansen BE; Wedemeyer H; Janssen HL; de Knegt RJ; Feld JJ
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1821-1830.e6. PubMed ID: 27404965
[TBL] [Abstract][Full Text] [Related]
10. The Optimal Timing of Hepatitis C Therapy in Transplant Eligible Patients With Child B and C Cirrhosis: A Cost-Effectiveness Analysis.
Tapper EB; Hughes MS; Buti M; Dufour JF; Flamm S; Firdoos S; Curry MP; Afdhal NH
Transplantation; 2017 May; 101(5):987-995. PubMed ID: 27495755
[TBL] [Abstract][Full Text] [Related]
11. Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates.
Gadiparthi C; Cholankeril G; Perumpail BJ; Yoo ER; Satapathy SK; Nair S; Ahmed A
World J Gastroenterol; 2018 Jan; 24(3):315-322. PubMed ID: 29391754
[TBL] [Abstract][Full Text] [Related]
12. The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities.
Cortesi PA; Belli LS; Facchetti R; Mazzarelli C; Perricone G; De Nicola S; Cesana G; Duvoux C; Mantovani LG; Strazzabosco M;
J Viral Hepat; 2018 Jul; 25(7):791-801. PubMed ID: 29406608
[TBL] [Abstract][Full Text] [Related]
13. Before or After Transplantation? A Review of the Cost Effectiveness of Treating Waitlisted Patients With Hepatitis C.
Tapper EB; Afdhal NH; Curry MP
Transplantation; 2017 May; 101(5):933-937. PubMed ID: 28437385
[TBL] [Abstract][Full Text] [Related]
14. Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list.
Chhatwal J; Samur S; Kues B; Ayer T; Roberts MS; Kanwal F; Hur C; Donnell DM; Chung RT
Hepatology; 2017 Mar; 65(3):777-788. PubMed ID: 27906468
[TBL] [Abstract][Full Text] [Related]
15. Safety of Direct-Acting Antiviral Therapy Regarding Renal Function in Post-Liver Transplant Patients Infected with Hepatitis C Virus and a 100% 12-Week Sustained Virologic Response-A Single-Center Study.
Peschel G; Moleda L; Baier L; Selgrad M; Schmid S; Scherer MN; Müller M; Weigand K
Transplant Proc; 2018 Jun; 50(5):1444-1450. PubMed ID: 29880368
[TBL] [Abstract][Full Text] [Related]
16. Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus.
Tahata Y; Hikita H; Mochida S; Enomoto N; Ido A; Kuroda H; Miki D; Kurosaki M; Hiasa Y; Sakamori R; Kawada N; Yamashita T; Suda G; Yatsuhashi H; Yoshiji H; Kato N; Takami T; Nakao K; Matsuura K; Asahina Y; Itoh Y; Tateishi R; Nakamoto Y; Kakazu E; Terai S; Shimizu M; Ueno Y; Akuta N; Miyazaki M; Nozaki Y; Kabayama M; Sobue S; Moriuchi A; Miyaki T; Kodama T; Tatsumi T; Yamada T; Takehara T
J Gastroenterol; 2023 Dec; 58(12):1211-1221. PubMed ID: 37831182
[TBL] [Abstract][Full Text] [Related]
17. No need to discontinue hepatitis C virus therapy at the time of liver transplantation.
Skoglund C; Lagging M; Castedal M
PLoS One; 2019; 14(2):e0211437. PubMed ID: 30794555
[TBL] [Abstract][Full Text] [Related]
18. Optimal timing for hepatitis C therapy in US patients eligible for liver transplantation: a cost-effectiveness analysis.
Njei B; McCarty TR; Fortune BE; Lim JK
Aliment Pharmacol Ther; 2016 Nov; 44(10):1090-1101. PubMed ID: 27640785
[TBL] [Abstract][Full Text] [Related]
19. Predictors of functional benefit of hepatitis C therapy in a 'real-life' cohort.
Steinebrunner N; Stein K; Sandig C; Bruckner T; Stremmel W; Pathil A
World J Gastroenterol; 2018 Feb; 24(7):852-861. PubMed ID: 29467555
[TBL] [Abstract][Full Text] [Related]
20. News and challenges in the treatment of hepatitis C in liver transplantation.
Coilly A; Roche B; Duclos-Vallée JC; Samuel D
Liver Int; 2016 Jan; 36 Suppl 1():34-42. PubMed ID: 26725895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
